Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(1;7)(q32;q34) SLC45A3/BRAF

Written2018-01Jean-Loup Huret, Philippe Dessen

(Note : for Links provided by Atlas : click)

Identity

Atlas_Id 6595
Phylum Prostate::
Note Non-annotated chromosomal abnormality. Preliminary data :
if you are an author who wish to write a full paper/card on this gene, go to  How to contribute

Clinics and Pathology

Disease Prostate:Male organs: Prostate cancer: t(1;7)(q32;q34) SLC45A3/BRAF

Genes involved and Proteins

Gene NameSLC45A3
Location 1q32.1

Gene NameBRAF
Location 7q34

Bibliography

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, Han B, Cao Q, Cao X, Suleman K, Kumar-Sinha C, Dhanasekaran SM, Chen YB, Esgueva R, Banerjee S, LaFargue CJ, Siddiqui J, Demichelis F, Moeller P, Bismar TA, Kuefer R, Fullen DR, Johnson TM, Greenson JK, Giordano TJ, Tan P, Tomlins SA, Varambally S, Rubin MA, Maher CA, Chinnaiyan AM
Nat Med 2010 Jul;16(7):793-8
PMID 20526349
 


Translocations implicated (Data extracted from papers in the Atlas)

 t(1;7)(q32;q34) SLC45A3/BRAF

External links

Mitelman database t(1;7)(q32;q34) [CaseList]    t(1;7)(q32;q34) [Transloc - MCList] SLC45A3/BRAF [Fusion - MCList]
COSMIC[ SLC45A3 ]   [ BRAF ]
arrayMap arrayMap ((UZH-SIB Zurich)   [auto + random 100 samples .. if exist ]   [tabulated segments]
 
 
Disease databaset(1;7)(q32;q34) SLC45A3/BRAF
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Feb 6 17:49:16 CET 2018


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.